Canadian General Electric

Oak Valley Health opens new Interventional Radiology Suite with first in Canada, innovative GE Healthcare technology

Retrieved on: 
Friday, April 8, 2022
RCC, GE Healthcare, Robotics, Oak Valley, Mental health, Hospital Insurance and Diagnostic Services Act, OHT, Whitchurch-Stouffville, GE, Hospital, General manager, MSH, Canadian General Electric, CEO, Intelligence, Thomas Edison, Health, Technology, York, Markham—Stouffville, Google Images, MPP, GLOBE, Physician, Solution, Infection, IR, UXB, Markham Stouffville Hospital, Patient, Volunteering, Medical imaging, Medical device, Medicine, Allia

ft. interventional radiology (IR) suite with the first in Canada GE Healthcare Allia IGS 7 system giving patients even more access to leading-edge treatments and procedures.

Key Points: 
  • ft. interventional radiology (IR) suite with the first in Canada GE Healthcare Allia IGS 7 system giving patients even more access to leading-edge treatments and procedures.
  • The centrepiece of the new IR Suite is the Allia IGS 7 image guided therapy system developed by GE Healthcare.
  • Ultimately, this will enable the team at Oak Valley Health to increase patient access and surgical capacity for the York, Durham regions.
  • Oak Valley Health is one of Ontarios leading community health systems.

Former JUUL Executives to Host Webinar to Discuss Poda

Retrieved on: 
Wednesday, September 8, 2021

VANCOUVER, BC, Sept. 8, 2021 /PRNewswire/ -PODA LIFESTYLE AND WELLNESS LTD. ("Poda" or the "Company") (CSE: PODA)(FSE: 99L) (OTC: PODAF) is pleased to announce that two former JUUL Executives, along with the CEO of Poda, will be hosting a webinar to discuss the Company on Wednesday, September 29th, 2021, at 12 pm EDT.

Key Points: 
  • VANCOUVER, BC, Sept. 8, 2021 /PRNewswire/ -PODA LIFESTYLE AND WELLNESS LTD. ("Poda" or the "Company") (CSE: PODA)(FSE: 99L) (OTC: PODAF) is pleased to announce that two former JUUL Executives, along with the CEO of Poda, will be hosting a webinar to discuss the Company on Wednesday, September 29th, 2021, at 12 pm EDT.
  • Michael was previously the president of JUUL Labs Canada, a division of JUUL Labs Inc. ("JUUL").
  • Altria Group, the maker of Marlboro cigarettes, invested $12.8 billion into JUUL in December 2018, acquiring a 35 percent stake.
  • Michael was hired by JUUL to launch the product and business unit in Canada.

Poda to Commence PMTA Process in the USA

Retrieved on: 
Tuesday, August 24, 2021
Company, FSE, Population, Comment, Federal Food, Drug, and Cosmetic Act, Pre-consultation Agreement (Japan), CSE, Public affairs, Smoking, Smokeless tobacco, Tobacco, Method, Public policy, Canadian General Electric, Smoker, Government Affairs Institute, Smell, Government, Canadian Securities Exchange, Nick, Food, Marketing, Heat, ALL, HNB, Multimedia, Public health, Board, FD, US FDA, NKO, Vail v. Juul Labs, Inc., Adult, OTC, News, Head, CEO, Wellness, US Foods, Corporate Affairs, US, Smoke, View, Pharmaceutical industry, Financial adviser

Pursuant to the Consulting Agreement, NKO will help to coordinate and oversee the entire PMTA process for certain Poda products.

Key Points: 
  • Pursuant to the Consulting Agreement, NKO will help to coordinate and oversee the entire PMTA process for certain Poda products.
  • Prior to receiving PMTA approval, however, Poda may be able to sell certain of its products in the USA that are not subject to PMTA authorization requirements.
  • Ryan Selby, CEO, commented, "Obtaining PMTA approval in the USA for certain Poda products is an important goal for the Company.
  • Obtaining marketing authorization under the PMTA for certain Poda products in the USA will allow us to expand our offerings in this Country."

Poda to Commence PMTA Process in the USA

Retrieved on: 
Tuesday, August 24, 2021
Company, FSE, Population, Comment, Federal Food, Drug, and Cosmetic Act, Pre-consultation Agreement (Japan), CSE, Public affairs, Smoking, Smokeless tobacco, Tobacco, Method, Public policy, Canadian General Electric, Smoker, Government Affairs Institute, Smell, Government, Canadian Securities Exchange, Nick, Food, Marketing, Heat, ALL, HNB, Public health, Board, FD, US FDA, NKO, Vail v. Juul Labs, Inc., Adult, OTC, News, Head, CEO, Wellness, US Foods, Corporate Affairs, US, Smoke, Pharmaceutical industry, Financial adviser

Pursuant to the Consulting Agreement, NKO will help to coordinate and oversee the entire PMTA process for certain Poda products.

Key Points: 
  • Pursuant to the Consulting Agreement, NKO will help to coordinate and oversee the entire PMTA process for certain Poda products.
  • Prior to receiving PMTA approval, however, Poda may be able to sell certain of its products in the USA that are not subject to PMTA authorization requirements.
  • Ryan Selby, CEO, commented, "Obtaining PMTA approval in the USA for certain Poda products is an important goal for the Company.
  • Obtaining marketing authorization under the PMTA for certain Poda products in the USA will allow us to expand our offerings in this Country."